Cytomos: Venture Capital Funding History

Cytomos

To add a bio or update company history, please click update information.

News from Cytomos

Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology

19 Nov 2024

Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology

Cytomos builds scalable cell analysis technology that measures intrinsic cellular properties in real time, helping biopharma companies accelerate drug discovery and manufacturing decisions.

Cytomos

Life Sciences
Edinburgh, United Kingdom
£5m
cytomos.com
Update Information

More venture news

adsilico
26 Oct 2026
adsilico unlocks a £10m Series A round led by PXN Ventures for virtual testing of implantable medical devices
Series ALife Sciences
imphatec
26 Oct 2026
imphatec raises a £1.5m seed round led by SynBioVen to develop customisable-dose implants for chronic conditions
SeedLife Sciences
OMass Therapeutics
15 Oct 2026
OMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
Series CLife Sciences

Cytomos: Venture Capital Funding History

News from Cytomos

Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology

More venture news

adsilico unlocks a £10m Series A round led by PXN Ventures for virtual testing of implantable medical devices

imphatec raises a £1.5m seed round led by SynBioVen to develop customisable-dose implants for chronic conditions

OMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform